BioPharma Dive February 20, 2025
Elise Reuter

The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an attorney said.

The sudden firing of Food and Drug Administration employees this past week is already affecting medical device companies.

The layoffs could delay the time it takes to bring new products to market and add pressure on remaining staff at the FDA’s device center. Advamed, one of the industry’s largest lobby groups, has criticized the cuts, saying they will negatively affect medical device makers and put patients at risk.

“We’ve heard from folks who have already gotten notice that current applications may be delayed or suspended,” Advamed CEO Scott Whitaker said on a Wednesday call...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Medical Devices
Valencia Technologies Secures Strategic Investment of $35 Million from Brooks Advisory Group, Appoints James D. Surek as CEO
Device industry scrambles as FDA job cuts cause delays
Pharma and medtech industry reacts to FDA, CDC and NIH job cuts
Avante appoints new CEO under Staple Street ownership
Micro-X gets $16 million contract to develop mobile full-body CT

Share This Article